Valuation Asymchem Laboratories (Tianjin) Co., Ltd. Hong Kong S.E.
Stocks
6821
CNE100004Z06
Pharmaceuticals
|
Delayed
Hong Kong S.E.
21:54:44 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 165.40 HKD | -1.08% |
|
+3.50% | +132.30% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 66,560 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 104.14% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 61,886 | 62,904 | 63,703 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 134.98% | 1.64% | 1.27% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 50.2x | 37.9x | 31.2x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 3.64x | 3.39x | 3.12x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 2.7x | 1.2x | 1.5x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 8.23x | 6.79x | 5.61x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 7.65x | 6.42x | 5.37x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 30.1x | 24.3x | 20.1x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 39.7x | 31.2x | 25.8x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -125x | 75.7x | 48x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -0.8% | 1.32% | 2.08% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.353 | 1.808 | 2.133 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.72% | 0.96% | 1.13% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.754 | 4.98 | 6.043 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 36% | 36.3% | 35.3% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,089 | 9,803 | 11,873 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,057 | 2,585 | 3,176 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,558 | 2,016 | 2,467 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,352 | 1,795 | 2,317 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -4,673 | -3,656 | -2,857 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 188.62 | 188.62 | 188.62 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,630 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | ||
| 28.48x | 6.32x | 17.74x | 2.09% | 617B | ||
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | ||
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | ||
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | ||
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | ||
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | ||
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | ||
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | ||
| Average | 26.61x | 6.52x | 17.28x | 2.29% | 410.8B | |
| Weighted average by Cap. | 31.80x | 7.61x | 18.61x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- 6821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















